¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"pacemaker cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
cell cycle
¼¼Æ÷ÁÖ±â
cell death
¼¼Æ÷»ç
cell dedifferentiation
¼¼Æ÷Å»ºÐÈ
cell division
¼¼Æ÷ºÐ¿
cell envelope
¼¼Æ÷²®Áú, ¼¼Æ÷ÇǸ·
cell fusion
¼¼Æ÷À¶ÇÕ
cell inclusion
¼¼Æ÷Æ÷ÇÔ¹°, ¼¼Æ÷ºÀÀÔü
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell line
¼¼Æ÷ÁÖ, ¼¼Æ÷°è
cell loss
¼¼Æ÷¼Ò½Ç
cell mass
¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
cell substitution
¼¼Æ÷´ëÄ¡, Ç÷±¸´ëÄ¡
cell swelling
¼¼Æ÷Á¾Ã¢
cell adhesion molecule
¼¼Æ÷ºÎÂøºÐÀÚ
cell agar plate
¼¼Æ÷¿ì¹«ÆòÆÇ
cell color ratio
ÀûÇ÷±¸»ö¼Òºñ
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell-associated virus
¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
cell-mediated cytolysis
¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
cell-mediated cytotoxicity
¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
cell-mediated hypersensitivity
¼¼Æ÷¸Å°³°ú¹Î
cell-mediated immunity
¼¼Æ÷¸Å°³¸é¿ª
cell-mediated reaction
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
¼±Æ÷ ¼¼Æ÷(àÍøàá¬øà)
acinar cell
¼±¹æ¼¼Æ÷(¡á¬øà)
acinic cell carcinoma
¼±¹æ¼¼Æ÷¾ÏÁ¾(¡á¬øàäßðþ)
acinic cell tumor
¼±¹æ¼¼Æ÷Á¾(¡á¬øàðþ)
activation, polyclonal B cell
´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
adamantinoid basal cell carcinoma
¹ý¶û Á¾¾ç(ÛöÕË ðþåÆ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
adult T Cell leukemia virus
¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult T cell leukemia virus (HTLV)
¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult t-cell leukemia/lymphoma
¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡á¬øà ÛÜúìÜ»/¡ðþ)
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
arsenical basal cell carcinoma
ºñ¼Ò¼º(Ý÷áÈàõ) ±âÀú¼¼Æ÷¾Ï
arteritis,giant cell of aorta
´ëµ¿¸Æ(ÓÞÔÑØæ)ÀÇ °Å¼¼Æ÷¼º(ËÝá¬øààõ)
aschoff cell
¾Æ¼îÇÁ ¼¼Æ÷(¡á¬øà)
aschoff giant cell
¾Æ¼îÇÁ °Å¼¼Æ÷(¡ËÝá¬øà)
asymmetric cell division
ºñ´ëμº ¼¼Æ÷ºÐ¿
autoimmune disease,bypass of t-helper cell(low zone)
T-º¸Á¶¼¼Æ÷ ³»¼º ¿ìȸ(¡ÜÍð¾á¬øàÒ±àõéæüß)
autosplenectomy,in sickle cell disease
°â»ó¼¼Æ÷º´(ÌÇßÒá¬øàÜ»)
axis of cell
¼¼Æ÷Ãà
b cell
B ¼¼Æ÷(¡á¬øà)
b7, in t cell anergy
B7, T-¼¼Æ÷ ¾Æ³×¸£±â
bacterial cell
±Õü, ±Õ¼¼Æ÷.
bacterial cell envelope
¼¼±Õ¿ÜÇÇ, ¼¼±Õ²®µ¥±â
bacterial cell membrane
¼¼±Õ¼¼Æ÷¸·
bacterial cell protein
±Õü´Ü¹é(Áú).
bacterial cell wall
¼¼±Õ¼¼Æ÷º®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½